Since the US Food and Drug Administration (FDA) approved the first thoracic endovascular aortic endograft repair (TEVAR) in 2005, its use has rapidly increased. , In a relatively short period of time, TEVAR for descending thoracic aortic aneurysms (DTAA) and…
Thoracic aortic pathology is one of the leading causes of death in the world in those over the age of 65 and in the United States accounts for more than 11,000 deaths annually. Thoracic aortic aneurysms (TAAs) occur less frequently…
Endovascular abdominal aortic aneurysm repair (EVAR) is predicated on complete exclusion of the aneurysm from the arterial circulation. An endoleak, or continued arterial perfusion of the aneurysm sac after endovascular treatment, can compromise the effectiveness of EVAR. There are five…
Historical Background Volodos and colleagues performed the first stent graft repair of an aortic pathology in 1987 in Kharkov, Union of Soviet Socialist Republics, but Parodi, Palmaz, and Barone are credited with pioneering and popularizing the technique in the early…